Bioscience Bulletin

G2G’s DC team was on Capitol Hill this week, alongside dozens of advocates and stakeholders from across the country.

The Congressionally Directed Medical Research Programs (CDMRP) has released pre-announcements for the FY 26 Spinal Cord Injury, ALS, Arthritis, Ovarian Cancer, Pancreatic Cancer and Tick-Borne Disease Research Programs.

The Congressionally Directed Medical Research Programs (CDMRP) has released pre-announcements for FY26 Breast Cancer Research Program (BCRP) and Lupus Research Program (LRP)

Federal Legislative Updates Ohio Legislative Updates G2G Blog G2G Bioscience Bulletin – February 7, 2026 Back to All Posts Funding Opportunity DARPA BTO has announced a new program, Protean. Key details…

ARPA-H announced a new program BIOmolecular Grammar for protein Aggregation Modulation and Intervention (BIOGAMI).

G2G Founder & CEO Liz Powell was in Birmingham, AL in her capacity as a leader of Women’s Health Advocates, to convene an event that brought together elected officials, medical professionals, doulas, community advocates and educators to examine the policies and systems shaping maternal health outcomes.

G2G Founder & CEO Liz Powell was at JP Morgan where she engaged with innovators, leaders and investors from across the healthcare and the life sciences sectors. Notably, Liz with other women’s health leaders presented the release of the Follow the Exits: Why Women’s Health Is a Smart Bet in Healthcare report.

G2G is co-leading a five-part webinar series on Navigating Government Systems for MedTech from January 27 to February 24

G2G was on Capitol Hill this week and met with Senate Health Education Labor & Pensions (HELP) Committee Chair Bill Cassidy (R-LA), and the offices of House Speaker Mike Johnson (R-LA) and Energy & Commerce Health Subcommittee Chair Morgan Griffith (R-VA) to advocate for the National Plan for Epilepsy Act.